Catalyst Wire Dossier Catalyst Wire Dossier

rhuMAb IFNalpha

rhuMAb IFNalpha · Genentech
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rhuMAb IFNalpha, covering 2011-09-22 to 2011-09-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of rhuMAb IFNalpha in Adults With Systemic Lupus Erythematosus [Phase 1]

See pricing